Immunome, Inc.

Associate Director / Director, Patient Marketing

Immunome, Inc.  •  $183k - $230k/yr  •  Bothell, WA (Onsite)  •  4 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.
65
AI Success™

Job Description

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets.

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets.

Immunome is seeking a strategic Patient Marketing Lead to design and deliver a best-in-class, end-to-end patient experience. Reporting to the Marketing Brand Lead, this individual will shape how patients are identified, educated, activated, and supported throughout their disease and treatment journey. Serving as the internal champion for the patient voice, the role translates complex clinical data into meaningful, patient-centric resources and drives high-impact media strategies to reach those in need. In close collaboration with HCP marketing and patient services, this leader will help ensure a seamless transition from awareness to access and ongoing support. The ideal candidate brings deep oncology expertise and a strong foundation in patient-centric marketing.

Responsibilities

Patient Strategy

  • Develop and execute a comprehensive U.S. patient marketing strategy across the product lifecycle, including unbranded disease awareness and branded campaigns
  • Maintain and continuously refine the patient journey by identifying new inflection points, emotional hurdles, and barriers to treatment through ongoing insights collection
  • Lead patient-focused market research, in collaboration with the market insights team, to ensure all brand messaging resonates with the lived experience of patients with desmoid tumors

Resource and Digital Ecosystem Development

  • Lead the creation of all patient-facing materials (i.e., patient discussion guide, patient starter kit) and partner closely with the HCP Marketing Lead to ensure patient resources are effectively utilized by the field in the clinical setting
  • Design and implement an integrated digital ecosystem (e.g., branded patient websites, paid search, social, CRM, programmatic) that supports education, activation, and treatment adherence
  • Establish foundational metrics/KPIs and optimize performance in real-time

Leadership and Collaboration

  • Lead the internal integration of patient insights across the organization, partnering with cross-functional teams to bridge the gap between clinical data and patient experience, ensuring a seamless and unified brand journey
  • Partner with patient services and market access teams to build messaging and support tools that address affordability, reimbursement, and treatment continuity
  • Coordinate with the Patient Advocacy team to ensure brand strategies align with the broader goals of the desmoid tumor community

Qualifications

  • Bachelor’s degree required; Advanced degree (e.g., PharmD, MBA) preferred
  • Oncology launch experience required
  • 7+ years of experience in pharmaceutical, biotech, or healthcare marketing, with a strong focus on patient marketing
  • Proven success in digital patient marketing (web, social, SEO/SEM, CRM, and paid media strategy) and media planning and execution
  • Deep understanding of the patient journey and emotional drivers of behavior in rare oncology disease populations
  • Experience collaborating with patient services (patient advocacy and PSP) to develop aligned messaging and support tools
  • Demonstrated ability to thrive in a fast-paced biotech environment
  • Ability to travel ≥20%, including occasional weekends

Knowledge and Skills

  • Ability to build clear and differentiated patient-friendly messaging to convey clinical benefit
  • Strong analytical and problem-solving skills, with the ability to leverage market research and performance data to inform decisions and optimize impact
  • Strong project management and operational execution skills; able to manage multiple workstreams and launch-critical deadlines in a fast-paced environment
  • Excellent communication, storytelling, and presentation skills—able to simplify complex clinical information for varied audiences
  • Experience managing agencies/vendors, budgets, and complex project plans with strong operational rigor and attention to detail
  • Strong understanding of MLR/PRC processes, claims substantiation, and OPDP regulations
  • Strong cross-functional leadership skills, including the ability to influence without authority

Washington State Pay Range $183,000$230,000 USD

E/E/O

Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

E-Verify

Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish)

Immunome, Inc.

About Immunome, Inc.

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.

Industry
Biotech & Life Sciences
Company Size
51-200 employees
Headquarters
Bothell, Washington
Year Founded
Unknown
Social Media